Ubrogepant relieves early migraine symptoms and may help prevent full-blown attacks
A phase 3 trial found that ubrogepant, given during the premonitory phase of migraine, improved common warning symptoms such as fatigue, light and sound sensitivity, and neck pain. These benefits…